ibrutinib,venetoclax,Obinutuzumab
roche,janssen,abbvie,biogen
['leusm', 'cll']
#eha2022 #lba b eichhorst presents cll13/gaia trial cit vs rv vs gv vs gvi in first line #cll #leusm 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @SIOGorg. Councilor @EHA_Hematology Executive Board. Chairman SWG “Aging and Hematology”